Click Here for 5% Off Your First Aladdin Purchase!

Rebamipide - ≥98%, high purity , CAS No.90098-04-7, Agonist of CCK 1 receptor

  • Moligand™
  • ≥98%
Item Number
R129303
Grouped product items
SKUSizeAvailabilityPrice Qty
R129303-1g
1g
In stock
$64.90
R129303-5g
5g
In stock
$182.90
R129303-10g
10g
In stock
$329.90
R129303-25g
25g
In stock
$741.90
R129303-100g
100g
In stock
$2,668.90

Derivative of 2-(1H)-quinolinone with multiple biological activities

View related series
CCK1 receptor Agonist

Basic Description

Synonymsrebamipide|90098-04-7|Proamipide|Mucosta|111911-87-6|OPC-12759|Rebamipide hydrate|139344-42-6|Pramipide|Rebator|2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid|2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid|NSC
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsRebamipide enhances mucosal resistance, increases prostaglandin in gastric mucosa, and also scavenges oxygen-derived free radicals and inhibits their production.Derivative of 2-(1 H )-quinolinone with multiple biological activities. Stimulates prostagland
Shipped InNormal
GradeMoligand™
Action TypeAGONIST
Mechanism of actionAgonist of CCK 1 receptor
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Rebamipide is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
An inducer of endogenous prostaglandin and a oxygen-derived free radical scavenger.


product description:

Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner;

Associated Targets

DRD1 Tclin D(1A) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ESR1 Tclin Estrogen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CCKAR Tclin Cholecystokinin receptor type A 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH3 Tclin Histamine H3 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLCO1B1 Tchem Solute carrier organic anion transporter family member 1B1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A2 Tclin Sodium-dependent noradrenaline transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A3 Tclin Sodium-dependent dopamine transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A4 Tclin Sodium-dependent serotonin transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PGR Tclin Progesterone receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE3A Tclin cGMP-inhibited 3',5'-cyclic phosphodiesterase A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS1 Tclin Prostaglandin G/H synthase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE4A Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD3 Tclin D(3) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM2 Tclin Muscarinic acetylcholine receptor M2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ACHE Tclin Acetylcholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2A Tclin Alpha-2A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1A Tclin Alpha-1A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAOA Tclin Amine oxidase [flavin-containing] A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1A Tclin 5-hydroxytryptamine receptor 1A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA3 Tchem Adenosine receptor A3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2B Tclin 5-hydroxytryptamine receptor 2B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TBXA2R Tclin Thromboxane A2 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

F2 Tclin Prothrombin 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Pubchem Sid488179871
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488179871
IUPAC Name 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
INCHI InChI=1S/C19H15ClN2O4/c20-13-7-5-11(6-8-13)18(24)22-16(19(25)26)9-12-10-17(23)21-15-4-2-1-3-14(12)15/h1-8,10,16H,9H2,(H,21,23)(H,22,24)(H,25,26)
InChi Key ALLWOAVDORUJLA-UHFFFAOYSA-N
Canonical SMILES C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
Isomeric SMILES C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
RTECS VC2518500
PubChem CID 5042
Molecular Weight 370.79
Reaxy-Rn 5384689

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

13 results found

Lot NumberCertificate TypeDateItem
I2212312Certificate of AnalysisJun 20, 2024 R129303
I2212313Certificate of AnalysisJun 20, 2024 R129303
I2212314Certificate of AnalysisJun 20, 2024 R129303
L2121598Certificate of AnalysisOct 08, 2023 R129303
L2121648Certificate of AnalysisOct 08, 2023 R129303
L2121651Certificate of AnalysisOct 08, 2023 R129303
H2329556Certificate of AnalysisAug 14, 2023 R129303
H2329758Certificate of AnalysisAug 14, 2023 R129303
H2329805Certificate of AnalysisAug 14, 2023 R129303
H2329806Certificate of AnalysisAug 14, 2023 R129303
F1502091Certificate of AnalysisJan 25, 2023 R129303
D23261178Certificate of AnalysisJul 24, 2022 R129303
I2212315Certificate of AnalysisJul 24, 2022 R129303

more

Chemical and Physical Properties

SolubilitySoluble in DMSO (74 mg/mL at 25 °C), methanol (Heat), water (<1 mg/mL at 25 °C), and ethanol (<1 mg/mL at 25 °C).
Melt Point(°C)290°C(dec.)(lit.)

Safety and Hazards(GHS)

Pictogram(s) GHS06
Signal Danger
Hazard Statements

H301:Toxic if swallowed

Precautionary Statements

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P301+P316:IF SWALLOWED: Get emergency medical help immediately.

RTECS VC2518500
Reaxy-Rn 5384689
Merck Index 8124

Related Documents

References

1. Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K.  (1992)  Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa..  Arzneimittelforschung,  42  (12): (1462-6).  [PMID:1337697]
2. Tarnawski AS, Chai J, Pai R, Chiou SK.  (2004)  Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?.  Dig Dis Sci,  49  (2): (202-9).  [PMID:15104358]
3. Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K.  (1995)  Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine..  Dig Dis Sci,  40  (11): (2469-72).  [PMID:7587834]
4. Yoshikawa T, Naito Y, Tanigawa T, Kondo M.  (1993)  Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance..  Arzneimittelforschung,  43  (3): (363-6).  [PMID:8387788]
5. Kleine A, Kluge S, Peskar BM.  (1993)  Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats..  Dig Dis Sci,  38  (8): (1441-9).  [PMID:8393757]
6. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A.  (1998)  Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing..  Dig Dis Sci,  43  (9 Suppl): (5S-13S).  [PMID:9753220]

Solution Calculators